Correction: Comparison of real-world efficacy and safety of nivolumab plus ipilimumab or pembrolizumab combined with platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer in a German population
Correction: Comparison of real-world efficacy and safety of nivolumab plus ipilimumab or pembrolizumab combined with platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer in a German population
Authors
- Alexander Freiherr von Hammerstein-Equord
- Achim Rittmeyer (ORCID: https://orcid.org/0000-0002-5280-6052)
- Manuela Weinreich
- Moritz Weber
- Stefan Andreas
Institutions
- Universitätsmedizin Göttingen (DE)
Publication Details
- Journal
- Cancer Immunology Immunotherapy
- Published
- 2026-04-06
- DOI
- https://doi.org/10.1007/s00262-026-04360-9
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Georg-August-Universität Göttingen